Log in
Enquire now
Evommune

Evommune

Evommune is a biotechnology company that develops therapeutics that halt progressive disease and address their symptoms.

OverviewStructured DataIssuesContributors

Contents

evommune.com
Is a
Company
Company
Organization
Organization

Company attributes

Industry
Pharmaceutical industry
Pharmaceutical industry
Healthcare
Healthcare
Biotechnology
Biotechnology
Location
Palo Alto, California
Palo Alto, California
B2X
B2C
B2C
CEO
‌
Luis Pena
Founder
‌
Hans Hofland
‌
Luis Pena
Pitchbook URL
pitchbook.com/profiles...453499-48
Legal Name
Evommune, Inc.0
Number of Employees (Ranges)
11 – 50
Investors
EQT Life Sciences
EQT Life Sciences
Pivotal bioVenture Partners
Pivotal bioVenture Partners
‌
LSP BioVentures
0
Marshall Wace
Marshall Wace
Longwood Fund
Longwood Fund
Sectoral Asset Management
Sectoral Asset Management
RA Capital Management
RA Capital Management
RTW Investments LLC
RTW Investments LLC
...
Total Funding Amount (USD)
198,000,000
Latest Funding Round Date
October 31, 2024
Latest Funding Type
Series C
Series C

Other attributes

Company Operating Status
Active
Latest Funding Round Amount (USD)
115,000,000
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Evommune

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.